K093989 is an FDA 510(k) clearance for the ORAL FLUID PHENCYCLIDINE. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on January 25, 2011 after a review of 397 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Chemistry FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.
View all Roche Diagnostics devices